Literature DB >> 11824853

Magnesium infusion improves endothelium-dependent vasodilation in the human forearm.

Arvo Haenni1, Kristina Johansson, Lars Lind, Hans Lithell.   

Abstract

The effect of intra-arterial magnesium infusion on endothelium-dependent vasodilation (EDV) in the forearm was studied in nine young healthy students (four men and five women). The EDV was assessed as forearm blood flow (FBF), measured by venous occlusion plethysmography, during infusion of methacholine (MCh). Endothelium-independent vasodilation (EIDV) was defined as FBF during infusion of sodium nitroprusside (SNP). During magnesium infusion in the brachial artery, 0.066 mmol/min, the concentration of ionized magnesium in venous plasma in the infused arm increased by 114%, from 0.59 (SD 0.04) to 1.26 (0.34) mmol/L (P = .0002). The FBF at baseline (ie, before administration of MCh or SNP) increased from 3.5 (1.1) to 7.3 (3.4) mL/min/100 mL tissue during magnesium infusion (P = .002). During low-dose MCh administration (2 microg/min), FBF increased by 24%, from 15.4 (5.5) to 19.1 (6.8) mL/min/100 mL tissue (P = .04), and during high-dose MCh administration (4 microg/min) FBF increased by 18%, from 20.3 (6.4) to 24.0 (7.2) mL/min/100 mL tissue (P = .04). The EIDV did not change significantly. Systemic blood pressure was not significantly altered by magnesium infusion. No change in FBF either at rest or during infusion of MCh or SNP was observed during the time-control protocol. In conclusion, this in vivo study showed that intraarterial magnesium infusion increased EDV in the infused human forearm, which is in accordance with findings in previous in vitro and animal experiments.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11824853     DOI: 10.1016/s0895-7061(01)02225-7

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  5 in total

1.  Intravenous magnesium for pediatric sickle cell vaso-occlusive crisis: methodological issues of a randomized controlled trial.

Authors:  Oluwakemi Badaki-Makun; J Paul Scott; Julie A Panepinto; T Charles Casper; Cheryl A Hillery; J Michael Dean; David C Brousseau
Journal:  Pediatr Blood Cancer       Date:  2014-01-17       Impact factor: 3.167

Review 2.  Magnesium and Hypertension: Decoding Novel Anti-hypertensives.

Authors:  Nassar Patni; Mahejabeen Fatima; Aselah Lamis; Shiza W Siddiqui; Tejaswini Ashok; Ahmad Muhammad
Journal:  Cureus       Date:  2022-06-10

3.  Microcirculatory changes during open label magnesium sulphate infusion in patients with severe sepsis and septic shock.

Authors:  Andrius Pranskunas; Namkje Ar Vellinga; Vidas Pilvinis; Matty Koopmans; E Christiaan Boerma
Journal:  BMC Anesthesiol       Date:  2011-06-14       Impact factor: 2.217

4.  Magnesium and vascular changes in hypertension.

Authors:  Ana Rosa Cunha; Bianca Umbelino; Margarida L Correia; Mario Fritsch Neves
Journal:  Int J Hypertens       Date:  2012-02-29       Impact factor: 2.420

5.  Paraneoplastic PRES from lymphoma induced hypercalcemia: Case report and review of the literature.

Authors:  Khaled Moussawi; Ethan I Meltzer; Seth N Levin; Sashank Prasad
Journal:  eNeurologicalSci       Date:  2018-11-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.